If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
75.10    -0.90 (-1.18%)
Bid:
74.90
Ask:
75.60
Spread: 0.70 (0.935%)
Market Cap: £361.21m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Results of AGM

31 Mar 2026 15:26

RNS Number : 9044Y
Chrysalis Investments Limited
31 March 2026
 

 

 

 

31 March 2026

 

Chrysalis Investments Limited

("Chrysalis" or the "Company")

 

Results of AGM

 

The Company announces the results of voting on the resolutions at its Annual General Meeting ("AGM") held at 12:00 on Tuesday, 31 March 2026. All resolutions were duly passed.

 

Andrew Haining, Chairman of Chrysalis commented: "The Board is firmly committed to acting in the best interests of shareholders, and we thank them for their continued support and confidence expressed at today's AGM. We remain resolute in executing our investment policy, ensuring an orderly realisation of assets and the efficient, timely return of capital. The Board will provide a fuller update on Company operations and ongoing management arrangements in our Quarterly NAV Announcement and Trading Update in early May." 

 

 

ORDINARY RESOLUTIONS

FOR

AGAINST

TOTAL VOTES

VOTES WITHHELD*

Votes

%

Votes

%

To receive the Company's Financial Report and Audited Financial Statements for the period from 1 October 2024 to 30 September 2025

 

288,914,813

99.73

776,029

0.27

289,697,042

1,090,953

To re-appoint KPMG Channel Islands Limited as auditor to the Company (the "Auditor") until the conclusion of the next general meeting at which accounts are laid before the Company

 

289,547,571

99.61

1,136,283

0.39

290,690,054

97,941

To authorise the directors of the Company (the "Directors") to determine the remuneration of the Auditor

 

289,908,138

99.73

791,657

0.27

290,705,995

82,000

ORDINARY RESOLUTIONS

FOR

AGAINST

FOR

AGAINST

Votes

%

Votes

%

To approve the report of the Remuneration & Nomination Committee for the year ended 30 September 2025

289,604,918

99.67

952,473

0.33

290,563,591

224,404

To re-elect Mr Andrew Haining as a Director of the Company who retires by rotation in accordance with Article 23.5 of the Articles

 

281,830,637

97.00

8,701,288

2.99

290,538,125

249,870

To re-elect Mr Stephen Coe as a Director of the Company who retires by rotation in accordance with Article 23.5 of the Articles

 

287,609,670

99.00

2,913,015

1.00

290,528,885

259,110

To re-elect Mr Tim Cruttenden as a Director of the Company who retires by rotation in accordance with Article 23.5 of the Articles

 

258,197,121

88.87

32,325,564

11.13

290,528,885

259,110

To re-elect Mr Simon Holden as a Director of the Company who retires by rotation in accordance with Article 23.5 of the Articles

 

268,267,786

99.04

2,584,804

0.95

270,858,790

19,929,205

To re-elect Ms Margaret O'Connor as a Director of the Company who retires by rotation in accordance with Article 23.5 of the Articles

259,845,064

89.44

30,677,621

10.56

290,528,885

259,110

 

ORDINARY RESOLUTIONS

FOR

AGAINST

TOTAL VOTES

VOTES WITHHELD*

Votes

%

Votes

%

To elect Mr Sam Dobyn as a Director of the Company who retires by rotation in accordance with Article 23.5 of the Articles

 

288,355,885

99.25

2,176,040

0.75

290,538,125

249,870

To approve the Company's dividend policy and authorise the Directors to declare and pay all dividends of the Company as interim dividends

 

286,810,898

98.69

3,792,514

1.31

290,609,612

178,383

SPECIAL RESOLUTIONS

FOR

AGAINST

TOTAL VOTES

VOTES WITHHELD*

Votes

%

Votes

%

To authorise the Company, pursuant to Article 3.11 of the Articles, to allot and issue or make offers or agreements to allot and issue, grant rights to subscribe for, or to convert any securities into ordinary shares of no-par value

 

280,988,541

96.70

9,573,878

3.29

290,568,619

219,376

To authorise the Company to make market acquisitions (as defined in the Companies (Guernsey) Law, 2008, as amended) of its own Ordinary Shares, either for cancellation or to hold as treasury shares for future resale or transfer

289,795,045

99.72

805,741

0.28

290,606,986

181,009

 

-ENDS-

 

 

For further information, please contact

 

Media

Montfort Communications:

Charlotte McMullen / Imogen Saunders

 

 

 

 

 

+44 (0) 7921 881 800

chrysalis@montfort.london

 

 

Investment Adviser

Chrysalis Investment Partners LLP:

James Simpson

 

+44 (0) 20 7871 5343

G10 Capital Limited (AIFM):

+44 (0) 20 7397 5450

Maria Baldwin

 

 

Barclays Bank PLC:

Dion Di Miceli / Stuart Muress / James Atkinson

 

 

+44 (0) 20 7623 2323

Panmure Liberum:

Chris Clarke / Darren Vickers

 

+44 (0) 20 3100 2222

Deutsche Numis:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

IQEQ Fund Services (Guernsey) Limited:

Aimee Gontier / Elaine Smeja

+44 (0) 1481 231852

 

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

The Company is an alternative investment fund ("AIF") for the purposes of the AIFM Directive and as such is required to have an investment manager who is duly authorised to undertake the role of an alternative investment fund manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ Group). Chrysalis Investment Partners LLP (FRN: 1009684) is an Appointed Representative of G10 Capital (FRN: 648953) Limited, which is authorised and regulated by the Financial Conduct Authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFLFFSVFILVIR
Date   Source Headline
30th Jun 20267:00 amRNSHalf-year Financial Report
15th Jun 20262:42 pmRNSHolding(s) in Company
18th May 20264:11 pmRNSDirector/PDMR Shareholding
12th May 202610:11 amRNSDirector/PDMR Shareholding
7th May 202611:38 amRNSDirector/PDMR Shareholding
5th May 20267:44 amRNSQuarterly NAV Announcement and Trading Update
5th May 20267:01 amRNSManagement Arrangements and Self-Managed Model
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20264:01 pmRNSResult of AGM
31st Mar 20263:26 pmRNSResults of AGM
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:24 pmRNSResults of EGM
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20269:50 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20269:59 amRNSTransaction in Own Shares
13th Mar 20269:59 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:21 pmRNSNotice of AGM
10th Mar 20264:21 pmRNSNotice of AGM
10th Mar 20267:01 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.